Infographics. The evolution of cancers in France

Better detected, better treated, cancer remains a subject of daily study. On the occasion of World Cancer Day, the National Cancer Institute (INCa) draws up 2014 review. While the incidence of cancer is declining among men (- 1.3%), it continues to increase at a slower pace among women (+ 0.2%).

Cancer is less and less synonymous with long hospital stays. The vast majority of cases are treated with chemotherapy, carried out in day hospitals. As the surgeries are less invasive, they also allow outpatient care. Moreover, this type of hospitalization has increased by 28% in oncology.

Despite progress in terms of treatment, patient mortality remains variable. Pleural mesothelioma and liver cancer remain extremely virulent, while testicular or thyroid cancer is increasingly cured.

355,000 new cases per year

Prostate cancer continues to dominate in men, as does breast cancer in women. In second position, a cancer that could most often be avoided, that of the colon-rectum.

Number of new cancer cases in 2014

Source : National Cancer Institute

148,000 annual deaths

Cancer is the leading cause of death in France. The increase is particularly marked among women (+ 20% in 32 years vs. + 11%).

Cancer mortality in 2014

Source : National Cancer Institute

Variable forecasts

	Cancers with increasing incidence and mortality are lung cancer in women, skin melanoma and cancer of the central nervous system in both sexes.
	Cancers whose incidence is increasing but mortality is declining are breast cancer in women and prostate cancer in men. They are more and more diagnosed, but early management helps ensure good survival.
	Cancers with declining mortality and incidence are cancers of the esophagus and cervix in women, and cancers of the esophagus or upper aero-digestive tract in men.

Cancer mortality

Geographic disparities are significant, for both men and women. The North, East, Île-de-France and Burgundy bear the heaviest female burden. The men, them, die more in the North, the North-East, the North-West and the center. The Alpine regions are the most spared.

Breakdown of cancer mortality in France

Cancer numbers

44,000 patients This is the number of patients included in clinical oncology trials. This is a strong increase since 2008 (+ 102%) with a strong participation of charities.

3 out of 5 people say they have retained the after-effects of their cancer, two years after their diagnosis, both physically and psychologically.

61% This is the employment rate after cancer. The situation of people with the disease deteriorates considerably in two years … while the continuation of work is possible.